​

Funding Round

Series D - Insilico Medicine

Series D - Insilico Medicine

Investment Firm

Overview

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Announced Date

Jun 06, 2022

Funding Type

Series D

Highlights

Location

Asia

Social

Investor Lead

N/A

Participant Investors

8

Investor Name
Participant InvestorWarburg Pincus
Participant InvestorDeerfield
Participant InvestorBold Capital Partners
Participant InvestorB Capital
Participant InvestorQiming Venture Partners

Round Details and Background

Insilico Medicine raised $60000000 on 2022-06-06 in Series D

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Company Funding History

11

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 18, 2017
Series A - Insilico Medicine
-4.0M
Feb 27, 2017
Series A - Insilico Medicine
2-2.8M
Nov 16, 2014
Convertible Note - Insilico Medicine
1-1.2M
Apr 16, 2014
Seed Round - Insilico Medicine
1-300.0K

Recent Activity

There is no recent news or activity for this profile.